AVBCC Value-Based Voices

Consolidation Versus Independence in Cancer Care

Is consolidation in cancer care truly the best path forward, or does independence offer greater benefits?In this episode of Value-Based Voices Sarah Alwardt, PhD, President, Avalere Health, and Jeff Patton, MD, CEO, OneOncology, discuss the nuances of consolidation versus independence in cancer care, the impact of policy and capital access, and the future of value-based oncology. Gain insights into sustainable models, data utilization, and patient-centered strategies.Contact Value-Based Voices - Follow AVBCC on LinkedIn - View our podcast lineup - Contact us at info@avbcc.org Thanks for listening!

Insights from JP Morgan 2026 with Liz Fowler, PhD, JD

Commercial health plans may have been missing from J.P. Morgan 2026, but government had a big presence! Value-Based Voices host Burt Zweigenhaft, PhD, and nationally recognized health policy expert Liz Fowler, PhD, JD, share their observations from this year’s meeting and key insights around most-favored nation prescription drug pricing, 340B, PBMs, Medicare site neutrality, AI, and of course value-based care. Contact Value-Based Voices - Follow AVBCC on LinkedIn - View our podcast lineup - Contact us at info@avbcc.org Thanks for listening!

More Insights from JP Morgan 2026 with Jeff Berkowitz, JD

Where was the drama at JP Morgan this year? Host Burt Zweigenhaft, PhD, and seasoned healthcare executive Jeff Berkowitz, JD, debate why the 2026 meeting seemed to be missing its normal electricity. They also share their thoughts around challenges with direct-to-patient models, most-favored-nation and its impact on product launch and pricing both in the US and Europe, and how AI may or may not be the key to finally achieving value-based outcomes. Contact Value-Based Voices - Follow AVBCC on LinkedIn - View our podcast lineup - Contact us at info@avbcc.org Thanks for listening!